Biologic Therapy for Osteoarthritis in San Jose, CA

What I’d check before adding osteoarthritis biologic therapy here

CDC PLACES (2023, crude) estimates 11.1% of adults in San Jose have diagnosed diabetes — 0.9 points below the U.S. 12% figure. Census city-proper population is 983,489. If you are adding osteoarthritis biologic therapy, start with that epidemiology and with Noridian Healthcare Solutions (JE) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 16.5% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 9.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in California.
• First Coast (Florida) is the only single-state MAC; every other state shares a contractor with neighbors. California is JE — copy-pasting a Florida LCD packet here is a denial pattern we still see.
• Staff turnover in a city of 500k–1M makes “we trained them last year” a weak control. HCT/P handling, centrifuge SOPs, and wound-photo standards need a named owner in the practice, not a one-time in-service.

Payer geography for San Jose, CA

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For San Jose we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 11.1% of adults in San Jose have diagnosed diabetes — 0.9 points below the U.S. 12% figure.

Staff, tickets, photos — in that order